EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...
For the first time, the European Medicines Agency has recognized AI software for the diagnosis of fatty liver hepatitis as ...
Galmed (GLMD) announced the grant of a new patent related to its lead compound, Aramchol. The patent covers the use of a combination therapy of ...
Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...
The doctor explained that beside alcohol consumption and hepatitis, hypertension can contribute significantly to liver fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback